Back

Pro-BNP variation as a risk marker of ventricular arrythmias in CRT patients

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence and diagnostic tools Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Luis Sousa Azevedo

Hospital Center of Tras-os-Montes and Alto Douro, Vila Real (Portugal)

5 More presentations in this session

Presentation thumbnail
Deep learning in electronic health records to predict incident heart failure by modelling temporal dependencies of antecedent risk factors
Miss S. Mahapatra (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Evaluating a large language model's ability to recommend guideline-directed medical therapy for heart failure: a pilot study
Mr J. Valk (Enschede, NL)
Abstract Slides Video
Presentation thumbnail
Stratification of patients with heart failure referred to cardiology at higher risk of 1-year heart failure admission or mortality by a machine learning algorithm
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Using AI to identify left ventricular ejection fraction from the ECG
Associate Professor M. Ciccarelli (Salerno, IT)
Abstract Slides Video
Presentation thumbnail
Improvement of biomarkers is associated with improved patient quality-of-life measures after heart failure hospitalisation: a sub-study of the Medly-AID randomised controlled trial
Doctor D. Brahmbhatt (Toronto, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Artificial intelligence and diagnostic tools

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
The association of NT-proBNP levels in atrial fibrillation patients and 3-year risk of heart hospitalization and death
thumbnail
Congress Presentation
Smaller intrinsic QRS area and smaller reduction of QRS area during cardiac resynchronisation therapy are associated with higher risk of ventricular arrhythmias and appropriate ICD therapy
thumbnail
Congress Presentation
Enhancing primary prevention: the incremental predictive value of NTproBNP beyond ASCVD risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources